EUVIMEDEUVIMED entdecken
Open Access

Risk of Suicidal Ideation and Behavior Following Early‐Onset Idiopathic Restless Legs Syndrome Treatment

Brianna Costales iD, Scott M Vouri iD, Joshua D Brown iD, Barry Setlow iD, Amie J Goodin iD

Pharmacoepidemiology and Drug Safety · 2024

DOI: 10.1002/pds.5852 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pharmacoepidemiology and Drug Safety, 2024. Verfasst von Brianna Costales und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutical Outcomes and Policy, Center for Drug Evaluation and Safety, College of Pharmacy, University of Florida, Gainesville, Flo…. Hauptthemen laut MEDLINE: Suicidal Ideation, Restless Legs Syndrome, Gabapentin. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIMH NIH HHS, National Institute of Mental Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

To estimate incidence rates of suicidal ideation and behavior following treatment initiation with gabapentinoids or dopamine agonists (DAs) in patients with newly diagnosed early‐onset idiopathic restless legs syndrome (RLS) and to examine suicidal behavior risk, comparing between those receiving gabapentinoids and DAs.

Methods

A new user retrospective cohort study using MarketScan claims data from 2012 to 2019 was conducted. Exposures were monotherapy gabapentinoids or DAs initiated within 60 days of new RLS diagnosis. Three varying outcome measures of suicidality were examined and incidence rates were calculated for each. A log‐binomial regression model the estimated relative risk (RR) of the outcomes with gabapentinoids. Propensity score weighting adjusted for baseline covariates, including age, substance use disorders, hyperlipidemia, antipsychotic use, hypnotic/sedative use, and mood stabilizer use, which were most imbalanced before weighting.

Results

The cohort included 6672 patients, with 4986 (74.7%) initiating a DA and 1686 (25.3%) initiating a gabapentinoid. Incidence rates for all outcome measures were higher in the gabapentinoid group (suicidality: 21.6 vs. 10.7 per 1000 person‐years; suicidality with self‐harm: 23.0 vs. 11.1 per 1000 person‐years; overdose‐ and suicide‐related events: 30.0 vs. 15.5 person‐years). Associated risk of suicidality (adjusted RR, 1.27 [95% CI, 0.86–1.88]); suicidality with self‐harm (adjusted RR, 1.30 [95% CI, 0.89–1.90]); or overdose‐ and suicide‐related events (adjusted RR, 1.30 [95% CI, 0.93–1.80]) was not significant with gabapentinoids.

Conclusions

Incidence rates for suicidal ideation and behavior were higher among the gabapentinoid group, although increased risk was not detected after adjustment. A possible signal cannot be ruled out given limitations of the data and rarity of the outcome.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Suicidal IdeationRestless Legs SyndromeGabapentinHumansFemaleMaleRetrospective StudiesAdultMiddle AgedIncidenceDopamine AgonistsYoung AdultCohort StudiesAgedAdolescentRisk Factors

Stichwörter der Autor:innen

Willis–Ekbom diseasedopamine agonistsgabapentinoidsidiopathicrestless legs syndromeself‐injurious behaviorsuicidal ideation

Substanzen

GabapentinDopamine Agonists

Autor:innen und Institutionen

  • Department of Pharmaceutical Outcomes and Policy, Center for Drug Evaluation and Safety, College of Pharmacy, University of Florida, Gainesville, Florida, USA.
  • Department of Psychiatry, College of Medicine, University of Florida, Gainesville, Florida, USA.

ORCID-Profile: Brianna Costales, Scott M Vouri, Joshua D Brown, Barry Setlow, Amie J Goodin

Förderung

  • NIMH NIH HHS
  • National Institute of Mental Health

Zitieren

APA

Costales, B., Vouri, S. M., Brown, J. D., Setlow, B., & Goodin, A. J. (2024). Risk of Suicidal Ideation and Behavior Following Early‐Onset Idiopathic Restless Legs Syndrome Treatment. Pharmacoepidemiology and Drug Safety. https://doi.org/10.1002/pds.5852

Vancouver

Costales B, Vouri SM, Brown JD, Setlow B, Goodin AJ. Risk of Suicidal Ideation and Behavior Following Early‐Onset Idiopathic Restless Legs Syndrome Treatment. Pharmacoepidemiology and Drug Safety. 2024. doi:10.1002/pds.5852

BibTeX
@article{Costales2024,
  author = {Costales, Brianna and Vouri, Scott M and Brown, Joshua D and Setlow, Barry and Goodin, Amie J},
  title = {Risk of Suicidal Ideation and Behavior Following Early‐Onset Idiopathic Restless Legs Syndrome Treatment},
  journal = {Pharmacoepidemiology and Drug Safety},
  year = {2024},
  doi = {10.1002/pds.5852}
}
Kostenlos starten →